Can you specify the age groups that participated in polivy's trials?

Polivy (polatuzumab vedotin) trials have enrolled adults only. Specifically:

- The pivotal trials included participants aged 18 years and older.
- There were no pediatric participants in the pivotal trials that supported approval.
- Exact age ranges and distributions depend on the specific trial (e.g., relapsed/refractory DLBCL trials vs frontline trials), but median ages were typically in the 60s, with a substantial proportion of participants aged 65 and older.

If you tell me which trial or indication you’re interested in (e.g., POLARIX frontline DLBCL trial, or the relapsed/refractory DLBCL Pola-BR trial), I can provide the precise age range, median, and any age subgroup breakdown from that study.